RLYB
Rallybio Corp
16.90$
-1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5,107.5% | – | -3,484.3% | -4,530.1% | -25,952.6% | -4,813.7% | -3,952.4% | -3,089.6% | -2,107.7% | -3,763.2% | – | 4,077.4% | |
| – | 15.8% | – | 11.4% | 10.7% | 78.9% | 13.2% | 12.3% | 16.5% | 1.4% | 1.4% | – | 6.7% | |
| – | 1,118.0% | – | 640.5% | 677.9% | 5,165.8% | 886.3% | 761.3% | 493.9% | 348.6% | 289.2% | – | 442.4% | |
| – | 2,656.1% | – | 1,270.2% | -1,706.0% | -2,434.2% | -1,438.7% | -212.3% | -559.0% | 222.1% | -125.0% | – | -164.7% | |
| – | 5.3% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | |
| – | 7,416.2% | – | 868.2% | 7,426.4% | -4,139.5% | 5,226.9% | 1,431.6% | 13,786.3% | 1,768.0% | 8,443.4% | – | 8,754.2% | |
| – | 123.7% | – | – | 14.7% | 47.4% | – | 4.7% | – | 2.7% | – | – | – | |
| – | 31.6% | – | 1,736.5% | -3.7% | 47.4% | 0.0% | 4.7% | 0.0% | 2.7% | 1.4% | – | 23.2% | |
| – | 2,340.4% | – | -879.6% | 2,892.6% | -30,044.7% | 413.2% | -2,516.0% | 10,696.7% | -336.9% | 4,681.6% | – | 12,854.8% | |
| – | -5,112.7% | – | -3,484.3% | -4,530.1% | -25,952.6% | -4,813.7% | -3,952.4% | -3,089.6% | -2,107.7% | -3,763.2% | – | 4,077.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.